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Abstract
The use of contrast-enhanced intraoperative ultrasound 
for hepatocellular carcinoma has been already proposed 
as a novel technique to stage the disease during sur-
gical resection. In the herein presented “letter to the 
editor”, the authors underline some important points, 
which have been raised following paper published in the 
January issue of World Journal of Gastroenterology . 
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TO THE EDITOR
The recent paper by Wu et al[1] entitled “Application of  
contrast-enhanced intraoperative ultrasonography in the 
decision-making about hepatocellular carcinoma opera-
tion” published in the January issue of  World Journal of  
Gastroenterology reports some experiences of  the authors in 
contrast-enhanced intraoperative ultrasound (CEIOUS) for 
hepatocellular carcinoma (HCC). This paper raises a couple 
of  questions that, we believe, need to be asked about. 
First and foremost, the authors did not mention any 
of  the previously performed and published studies on the 
same topic on the application of  CEIOUS for HCC[2-7]. 
Such studies not only represent the first pioneer investi-
gations on CEIOUS, but up to now they are the corner-
stones of  this new intraoperative imaging modality, which 
needs to be confirmed or confuted by further studies per-
formed by other groups. In this sense, Wu et al[1] have lost 
this opportunity.
Second, it is unclear to the readers how the authors 
defined a lesion as malignant based on the CEIOUS 
findings. This is a pivotal point. Yet, CEIOUS for HCC 
requires a kind of  classification to interpret its findings in 
order to make the correct diagnosis. In particular in case 
of  cirrhotic liver, where the finding of  multiple subcenti-
metric nodules is common, the typical arterial phase might 
not be very clear because some of  those nodules are high-
grade dysplastic nodules or early HCC with no anticipated 
standard contrast enhancement. Indeed, we proposed a 
classification that, we believe, could help in this sense, 
even if  it probably requires some refinements[8].
Third, the reported value of  specificity for CEIOUS 
is very high compared with that for intraoperative ultra-
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sound (IOUS) and contrast-enhanced magnetic resonance 
imaging (CEMRI). The impression is that the authors 
calculated the specificity by adding the value of  CEMRI 
and IOUS. When CEIOUS was performed on the same 
population of  patients who had CEMRI and IOUS, its re-
sults in terms of  sensitivity and specificity might be biased 
by the previous radiological findings. Only a true blind 
performance of  different diagnostic methods might allow 
a true comparison in terms of  diagnostic accuracy. 
Finally, we thank that Wu et al[1], because our group, de-
veloped and supported the study of  CEIOUS performed 
many years ago, both for HCC[2,4-6] and for colorectal liver 
metastases[9]. Thus, any new study on the same topic fur-
ther sustains its use. 
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